C. Cortes

发表

Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS)

Ted M. Lakowski, T. Lakowski, M. Namaka, 2015, Molecular Neurobiology.

Spinal Cord Brain Derived Neurotrophic Factor (BDNF) Responsive Cells in an Experimental Autoimmune Encephalomyelitis (EAE) Model of Multiple Sclerosis (MS): Implications in Myelin Repair

T. Klonisch, M. Doupe, M. Namaka, 2014 .

A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation

S. DeArmond, J. Mastrianni, R. Wollman, 2008, Neurology.

Elevation of Tumor Necrosis Factor Alpha in Dorsal Root Ganglia and Spinal Cord is Associated with Neuroimmune Modulation of Pain in an Animal Model of Multiple Sclerosis

M. Namaka, B. Macneil, C. Cortes, 2013, Journal of Neuroimmune Pharmacology.

Influence of the intensity, level and phase of spinal cord injury on the proliferation of T cells and T-cell-dependent antibody reactions in rats

A. Ibarra, A. Jiménez, C. Cortes, 2007, Spinal Cord.

Elevation of Tumor Necrosis Factor Alpha in Dorsal Root Ganglia and Spinal Cord is Associated with Neuroimmune Modulation of Pain in an Animal Model of Multiple Sclerosis

M. Namaka, B. Macneil, C. Cortes, 2013, Journal of Neuroimmune Pharmacology.

Home Intervention for Children with Unilateral Upper Limb Reduction Deficiencies

Jordan A. Borrell, C. Cortes, J. Zuniga, 2021 .

Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain

Howard M. Intrater, M. Namaka, B. Macneil, 2013, BioMed research international.

Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.

Ted M. Lakowski, M. Namaka, C. Cortes, 2016, Future medicinal chemistry.

Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage

Ted M. Lakowski, M. Namaka, C. Cortes, 2017, International journal of molecular sciences.

Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS)

Ted M. Lakowski, M. Namaka, T. Khorshidahmad, 2016, Molecular Neurobiology.

Exploring the role of nerve growth factor in multiple sclerosis: implications in myelin repair.

M. Namaka, C. Acosta, C. Cortes, 2014, CNS & neurological disorders drug targets.

On Mining Biological Signals Using Correlation Networks

Hesham H. Ali, Kathryn Dempsey, Ishwor Thapa, 2013, 2013 IEEE 13th International Conference on Data Mining Workshops.

Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin Repair.

M. Torabi, F. Burczynski, M. Namaka, 2015, CNS & neurological disorders drug targets.